Arbuscular mycorrhizal fungi affect total phenolic content and antimicrobial activity of Tamarix gallica in natural semi-arid Algerian areas

Autor: Bencherif, K., Djaballah, Z., Brahimi, F., Boutekrabt, A., Dalpè, Y., Lounès-Hadj Sahraoui, A.

Publikováno v: In South African Journal of Botany September 2019 125:39-45

GD2 and GD3 gangliosides as diagnostic biomarkers for all stages and subtypes of epithelial ovarian cancer.

Autor: Galan A; Translational Cancer Center, Lady Davis Institute-Jewish General Hospital, McGill University, Montreal, QC, Canada., Papaluca A; Translational Cancer Center, Lady Davis Institute-Jewish General Hospital, McGill University, Montreal, QC, Canada.; Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada., Nejatie A; Translational Cancer Center, Lady Davis Institute-Jewish General Hospital, McGill University, Montreal, QC, Canada.; Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada., Matanes E; Translational Cancer Center, Lady Davis Institute-Jewish General Hospital, McGill University, Montreal, QC, Canada.; Department of Ob-Gyn, Jewish General Hospital, McGill University and Segal Cancer Center, Lady Davis Institute of Medical Research, Montreal, QC, Canada., Brahimi F; Translational Cancer Center, Lady Davis Institute-Jewish General Hospital, McGill University, Montreal, QC, Canada., Tong W; Translational Cancer Center, Lady Davis Institute-Jewish General Hospital, McGill University, Montreal, QC, Canada.; Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada., Hachim IY; Clinical Sciences Department, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates., Yasmeen A; Department of Ob-Gyn, Jewish General Hospital, McGill University and Segal Cancer Center, Lady Davis Institute of Medical Research, Montreal, QC, Canada., Carmona E; Centre de recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM) and Institut du Cancer de Montréal, Montreal, QC, Canada., Klein KO; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Université de Montréal, Montreal, QC, Canada.; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC, and Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada., Billes S; R&D Department, AOA Dx Inc, Cambridge, MA, United States., Dawod AE; R&D Department, AOA Dx Inc, Cambridge, MA, United States., Gawande P; R&D Department, AOA Dx Inc, Cambridge, MA, United States., Jeter AM; R&D Department, AOA Dx Inc, Cambridge, MA, United States., Mes-Masson AM; Centre de recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM) and Institut du Cancer de Montréal, Montreal, QC, Canada.; Department of Medicine, Université de Montréal, Montreal, QC, Canada., Greenwood CMT; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Université de Montréal, Montreal, QC, Canada.; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC, and Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada., Gotlieb WH; Translational Cancer Center, Lady Davis Institute-Jewish General Hospital, McGill University, Montreal, QC, Canada.; Department of Ob-Gyn, Jewish General Hospital, McGill University and Segal Cancer Center, Lady Davis Institute of Medical Research, Montreal, QC, Canada., Saragovi HU; Translational Cancer Center, Lady Davis Institute-Jewish General Hospital, McGill University, Montreal, QC, Canada.; Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada.; Ophthalmology and Vision Science. McGill University, Montreal, QC, Canada.

Publikováno v: Frontiers in oncology [Front Oncol] 2023 Apr 14; Vol. 13, pp. 1134763. Date of Electronic Publication: 2023 Apr 14 (Print Publication: 2023).

Therapeutic Neuroprotection by an Engineered Neurotrophin that Selectively Activates Tropomyosin Receptor Kinase (Trk) Family Neurotrophin Receptors but Not the p75 Neurotrophin Receptor.

Autor: Brahimi F; Lady Davis Institute-Jewish General Hospital (F.B., A.G., H.U.S.), Pharmacology and Therapeutics (H.U.S.), and Ophthalmology and Vision Science (H.U.S.), McGill University, Montreal, Quebec, Canada; Otonomy, Inc., San Diego, California (S.Si., S.Sz., A.C.F.); and School of Engineering Science, Simon Fraser University, British Columbia, Canada (M.V.S.)., Galan A; Lady Davis Institute-Jewish General Hospital (F.B., A.G., H.U.S.), Pharmacology and Therapeutics (H.U.S.), and Ophthalmology and Vision Science (H.U.S.), McGill University, Montreal, Quebec, Canada; Otonomy, Inc., San Diego, California (S.Si., S.Sz., A.C.F.); and School of Engineering Science, Simon Fraser University, British Columbia, Canada (M.V.S.)., Siegel S; Lady Davis Institute-Jewish General Hospital (F.B., A.G., H.U.S.), Pharmacology and Therapeutics (H.U.S.), and Ophthalmology and Vision Science (H.U.S.), McGill University, Montreal, Quebec, Canada; Otonomy, Inc., San Diego, California (S.Si., S.Sz., A.C.F.); and School of Engineering Science, Simon Fraser University, British Columbia, Canada (M.V.S.)., Szobota S; Lady Davis Institute-Jewish General Hospital (F.B., A.G., H.U.S.), Pharmacology and Therapeutics (H.U.S.), and Ophthalmology and Vision Science (H.U.S.), McGill University, Montreal, Quebec, Canada; Otonomy, Inc., San Diego, California (S.Si., S.Sz., A.C.F.); and School of Engineering Science, Simon Fraser University, British Columbia, Canada (M.V.S.)., Sarunic MV; Lady Davis Institute-Jewish General Hospital (F.B., A.G., H.U.S.), Pharmacology and Therapeutics (H.U.S.), and Ophthalmology and Vision Science (H.U.S.), McGill University, Montreal, Quebec, Canada; Otonomy, Inc., San Diego, California (S.Si., S.Sz., A.C.F.); and School of Engineering Science, Simon Fraser University, British Columbia, Canada (M.V.S.)., Foster AC; Lady Davis Institute-Jewish General Hospital (F.B., A.G., H.U.S.), Pharmacology and Therapeutics (H.U.S.), and Ophthalmology and Vision Science (H.U.S.), McGill University, Montreal, Quebec, Canada; Otonomy, Inc., San Diego, California (S.Si., S.Sz., A.C.F.); and School of Engineering Science, Simon Fraser University, British Columbia, Canada (M.V.S.)., Saragovi HU; Lady Davis Institute-Jewish General Hospital (F.B., A.G., H.U.S.), Pharmacology and Therapeutics (H.U.S.), and Ophthalmology and Vision Science (H.U.S.), McGill University, Montreal, Quebec, Canada; Otonomy, Inc., San Diego, California (S.Si., S.Sz., A.C.F.); and School of Engineering Science, Simon Fraser University, British Columbia, Canada (M.V.S.) uri.saragovi@mcgill.ca.

Publikováno v: Molecular pharmacology [Mol Pharmacol] 2021 Nov; Vol. 100 (5), pp. 491-501. Date of Electronic Publication: 2021 Aug 31.

Antibacterial Properties and Biocompatibility of Multicomponent Titanium Oxides: A Review.

Autor: Straumal, Boris B.¹ (AUTHOR) kurkin@icp.ac.ru, Kurkin, Evgenii N.¹ (AUTHOR), Balihin, Igor L.¹ (AUTHOR), Klyatskina, Elisaveta¹ (AUTHOR), Straumal, Peter B.¹ (AUTHOR), Anisimova, Natalia Yu.¹ (AUTHOR), Kiselevskiy, Mikhail V.¹ (AUTHOR)

Publikováno v: Materials (1996-1944). Dec2024, Vol. 17 Issue 23, p5847. 32p.

Energy and Economic Analysis of a New Combination Cascade Waste Heat Recovery System of a Waste-to-Energy Plant.

Autor: Ling, Jialu¹ (AUTHOR), Chen, Xinjian² (AUTHOR) xjchen@gxu.edu.cn

Publikováno v: Energies (19961073). Oct2024, Vol. 17 Issue 20, p5196. 16p.